Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57,280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter phase I dose escalation and expansion study of pyrotinib in combination with camrelizumab and chemotherapy as first-line treatment for HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma.
Li S, Bao J, Li X, Yang Q, Xu J, Chen S, Feng G, Gao C, Feng L, Lu B, Miao M, Ni X, Wang G, Yang L, Zhu L. Li S, et al. Among authors: yang q, yang l. EClinicalMedicine. 2023 Nov 20;66:102314. doi: 10.1016/j.eclinm.2023.102314. eCollection 2023 Dec. EClinicalMedicine. 2023. PMID: 38024480 Free PMC article.
Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial.
Zhao X, Chen Z, Zhang X, Zhu X, Zhang W, Qiu L, Wang C, Huang M, Zhang Z, Li W, Yang L, Guo W. Zhao X, et al. Among authors: yang l. Cancer Biol Med. 2023 Aug 31;20(9):682-8. doi: 10.20892/j.issn.2095-3941.2023.0112. Cancer Biol Med. 2023. PMID: 37653589 Free PMC article. Clinical Trial.
57,280 results
You have reached the last available page of results. Please see the User Guide for more information.